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We describe different neuropharmacological effects of Verbena officinalis crude extract
(Vo.Cr). Pentylenetetrazole (PTZ)-induced seizures, elevated plus maze, light–dark box
(LDB), open field and thiopental-induced sleeping test models were employed to
evaluate Vo.Cr actions in mice. Vo.Cr dose-dependently (100–500 mg/Kg) delayed
onset time of myoclonic jerks and tonic-clonic seizures, while decreased duration of
tonic-clonic seizures (P < 0.05, P < 0.001 vs. saline group). Vo.Cr at 100 and 300–
500 mg/Kg doses reduced animals’ mortality in PTZ-induced seizures test to 75 and
0%, respectively. Vo.Cr (50–300 mg/Kg) significantly increased time spent and number
of entries into open arms, while decreased time spent and number of entries into closed
arms (P < 0.05, P < 0.01, P < 0.001 vs. saline group), measured in elevated plus maze.
Vo.Cr (50–300 mg/Kg) increased time spent in light compartment, while decreased time
spent in dark compartment (P < 0.01, P < 0.001 vs. saline group) in LDB, like caused
by diazepam. In open field test, Vo.Cr decreased number of ambulations and rearings
frequencies, while increased the number of central squares crossings. In thiopental-
induced sleeping test, Vo.Cr (50–300 mg/Kg) decreased onset time of sleep, while
increased the duration of sleep (P < 0.05, P < 0.01, P < 0.001 vs. saline group). These
results indicate that Verbena officinalis possess anticonvulsant, anxiolytic and sedative
activities, which provides scientific background for its medicinal application in various
neurological ailments, such as epilepsy, anxiety, and insomnia.
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INTRODUCTION
Verbena officinalis is a perennial herb, belongs to family Verbenaceae, commonly known as
“Vervian,” “Herb of grace,” “Pigeon’s grass” and localy “Karenta” or “Pamukh.” It mostly grows in
Europe and Asia, commonly found in cultivated fields and wastelands near water and cultivated in
Northern and Western areas of Pakistan (Jafri et al., 1974; Khan et al., 2015). It grows up to height
of about 1 m, having lobed and toothed leaves, while flowers are elegant, silky and pale purple in
color (Voogelbreinde, 2009). In traditional system of medicine, Verbena officinalis has been used
for treatment of melancholia, hysteria, seizures, jaundice, fever, cholecystaliga, anxiety, depression,
insomnia, menstrual disorders (Khare, 2007), abdominal problems, malaria, pharyngitis, edema
(Kou et al., 2013), cough, asthma (Vitalini et al., 2009), rheumatic and thyroid problems
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(Guarrera et al., 2005) etc. The constituents isolated from
Verbena officinalis include verbenin, verbenalin, hastatoside,
alpha-sitosterol, ursolic acid, oleanolic acid (Duke, 1992),
kaempferol, luteolin (Chen et al., 2006), verbascoside, aucubin,
apigenin, scutellarein (Rehecho et al., 2011) and essential oils
like limonene, cineole, spathulenol, ar-curcumeme (Chalchat
and Garry, 1995). The plant is reported to possess antitussive
(Gui and Tang, 1985), analgesic, anti-inflammatory (Calvo,
2006), neuroprotective (Lai et al., 2006), Antiradical (Speroni
et al., 2007), antioxidant, antifungal (López et al., 2008), anti-
tumor (Kou et al., 2013), antibacterial (Mengiste et al., 2015),
Antiproliferative (Encalada et al., 2015), and antidepressant
(Kamal et al., 2015) activities. In this investigation, we report
anticonvulsant, anxiolytic and sedative actions of Verbena
officinalis, which explains its ethno-medicinal use in neurological
disorders.
MATERIALS AND METHODS
Plant Material and Extraction
Verbena officinalis whole plant (3.2 Kg) was collected from
National Industrial State, Rawat, Islamabad, Pakistan and was
verified by Dr. Mushtaq Ahmad, a Plant Taxonomist, Department
of Plant Science, Quaid-e-Azam University, Islamabad, Pakistan.
A voucher specimen number 270 was deposited at the same
Department for future reference. The plant material was shade
dried until water evaporated completely and then grinded. The
coarse powder (2.7 Kg) was macerated in 70% aqueous-methanol
under room conditions for 2-weeks with gentle occasional
shaking. The extract was filtered and then concentrated in
vacuum under reduced pressure using rotary evaporator to
obtain a blackish thick paste of Verbena officinalis crude extract
(Vo.Cr), which was completely solublized in normal saline
(0.9% w/v). The percentage yield of extract was found to be
18.66% w/w.
Animals
Swiss albino mice (25–35 g) of either sex were used for
this study, housed in Animal House of Riphah Institute of
Pharmaceutical Sciences in polypropylene (22 cm × 37 cm)
cages under standard laboratory environment; 25 ± 2◦C, light
and darkness duration were for 12 h each and had free
access to standard diet and water ad libitum. Experiments
performed complied with rules of Institute of Laboratory Animal
Resources, Commission on Life Sciences University, National
Research Council (1996), approved by Ethical Committee
of Riphah Institute of Pharmaceutical Sciences (Ref. No:
REC/RIPS/2015/006).
Drugs and Chemicals
Diazepam (Valium 10 mg/2 mL injection), pentylenetetrazole
(PTZ) and thiopental sodium (Pentothal 500 mg dry powder for
injection) were obtained from Roche Pharmaceuticals, Pakistan,
Sigma-Aldrich, Co. LLC, USA and Abbot Laboratories, Pakistan,
respectively.
EXPERIMENTAL PROTOCOLS
Anticonvulsant Study
PTZ-Induced Seizures
Mice were divided into five groups (each having four animals)
and injected (i.p) with normal saline (10 mL/Kg), Vo.Cr (100–
500 mg/Kg), and diazepam (1 mg/Kg). Thirty min later to
saline, Vo.Cr and diazepam treatment, an i.p. dose of PTZ
(90 mg/Kg) was given to all animals and each animal was
observed for onset time of myoclonic jerks and tonic-clonic
seizures, as well as duration of tonic-clonic seizures for 30 min.
Drugs that delayed onset of myoclonic jerks, tonic-clonic
seizures and/or shortened duration of tonic-clonic seizures are
considered to exhibit anticonvulsant effect (Bum et al., 2008; Ya’u
et al., 2008). The animals were also observed for mortality (%
mortality = number of mice died after convulsion/total number
of mice used× 100).
Anxiolytic Assays
Elevated Plus Maze (EPM)
Test EPM model consist of a wooden apparatus having four
arms (two open arms of 30 cm × 5 cm and two closed arms
of 30 cm × 5 cm × 15 cm) connected via a central opened
area (5 cm × 5 cm), elevated up to 40 cm from the floor, as
previously described (Karim et al., 2012). The edges of open arms
are surrounded by 3 mm high and 1 mm thick wall. Mice were
divided into five groups (each having four animals), received an
i.p. dose of normal saline (10 mL/Kg) and Vo.Cr (50–300 mg/Kg)
once/day for 7 days, while one group was treated with diazepam
(2 mg/Kg), injected once time 30 min prior to test. After 30 min
of saline, Vo.Cr and diazepam treatment, a 5 min test was
performed by placing each mouse on central area and recorded
time spent and number of entries into open and closed arms, via
a digital video camera. An entry was considered, when mouse
placed all four paws in any arm. The total number of entries into
and total time spent in open and closed arms were calculated for
determining anxiolytic activity. Following each trial, apparatus
was cleaned with 70% aqueous-ethanol.
Light–Dark Box (LDB) Technique
Light–dark box (LDB) model contains wooden box of
dimensions 44 cm × 21 cm × 21 cm and divided into a
small compartment (1/3rd), painted black inside and covered
with a wooden lid and a large compartment (2/3rd) which was
painted white, covered by a transparent glass and illuminated
by a 60 watt bulb. The two compartments were separated by a
wooden blank, having a hole of 7 cm × 7 cm in center at surface
of floor. Mice were divided into five groups (each having four
animals), received an i.p. dose of normal saline (10 mL/Kg)
and Vo.Cr (50–300 mg/Kg) once/day for 7 days, while one
group was treated with diazepam (2 mg/Kg), injected once time
30 min prior to test. After 30 min of saline, Vo.Cr and diazepam
treatment, a 5 min test was performed by placing each mouse
in center of lighted box, keeping face away of opening hole and
time spent in each compartment was recorded via a digital video
camera (Belzung et al., 1987; Bourin and Hascoet, 2003).
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Open Field Test
The apparatus is made of a wooden base divided into 12 equal
squares with glass walls of dimensions (50 cm× 25 cm× 50 cm).
Mice were divided into five groups (each having four animals),
received an i.p. dose of normal saline (10 mL/Kg) and Vo.Cr
(50–300 mg/Kg) once/day for 7 days, while one group was
treated with diazepam (2 mg/Kg), injected once time 30 min
prior to test. After 30 min of saline, Vo.Cr and diazepam
treatment, a 5 min test was performed by placing each mouse
in corner square to explore the arena and recorded numbers
of ambulations, rearings, and central squares crossings (Brown
et al., 1999; Maurmann et al., 2011), via digital video camera.
Ambulations mean number of total squares crossed by mice,
rearings are the number of times mice stood on its hind limbs
and central squares crossings are the number of times mice
entered the central squares with its all four paws. Central
squares are those that are not adjacent to arena walls. A square
number was counted when mice enter in square with all four
paws.
Sedative Activity
Thiopental-Induced Sleeping Assay
Thiopental-induced sleeping test was used for determining
sedative activity (Alnamer et al., 2012). Mice were divided into
five groups (each having four animals), received an i.p. dose of
normal saline (10 mL/Kg), Vo.Cr (50–300 mg/Kg), and diazepam
(3 mg/Kg). Thirty min later to saline, Vo.Cr and diazepam
treatment, an i.p. dose of thiopental sodium (50 mg/Kg) was
given to all animals for induction of sleep. As thiopental sodium
was injected, mice were placed in a test arena for observing the
onset and duration of sleep.
Acute Toxicity Test
Mice in two groups were administered with Vo.Cr high doses
of 3 and 5 g/Kg, i.p, then kept under observation for 24 h and
observed for toxicity symptoms or death.
Statistical Analysis
Data expressed are mean ± standard error of mean (SEM,
n= number of experiments). The statistical parameter applied is
one-way analysis of variance (ANOVA) with Tukey post hoc test.
P< 0.05 was noted as significantly different. The bar-graphs were
analyzed using Graph Pad program (GraphPAD, San Diego, CA,
USA).
RESULTS
Effect on PTZ-Induced Seizures
Vo.Cr dose-dependently (100–500 mg/Kg) delayed onset time of
PTZ (90 mg/Kg) mediated both myclonic jerks and tonic-clonic
seizures, while decreased duration time of tonic-clonic seizures
(Figure 1). In control saline group, onset times of myoclonic
jerks, tonic-clonic seizures and duration of tonic-clonic seizures
were 35.25 ± 5.39, 42 ± 5.05, and 45 ± 2.74 s, respectively.
In Vo.Cr (100 mg/Kg) treated group, onset times of myoclonic
jerks and tonic-clonic seizures increased to 55.25 ± 6.09 and
FIGURE 1 | Bar-graph showing effects of Verbena officinalis crude
extract (Vo.Cr) and diazepam on onset time of
pentylenetetrazole-induced myoclonic jerks, tonic-clonic seizures and
duration of tonic-clonic seizures in mice. Data expressed as
mean ± SEM, n = 4. ∗P < 0.05, ∗∗∗P < 0.001 vs. saline group, one-way
ANOVA with post hoc Tukey test.
62 ± 4.97 s, respectively (P < 0.05 vs. saline group), while
duration time of tonic-clonic seizures reduced to 35.75 ± 3.59 s.
In Vo.Cr (300 mg/Kg) treated group, onset times of myoclonic
jerks and tonic-clonic seizures increased to 75 ± 1.58 and
79.25 ± 2.56 s, respectively (P < 0.001 vs. saline group), while
duration time of tonic-clonic seizures reduced to 30.25 ± 2.32 s
(P < 0.05 vs. saline group). In Vo.Cr (500 mg/Kg) treated group,
onset times of myoclonic jerks and tonic-clonic seizures increased
to 87.25 ± 4.03 and 118.25 ± 3.79 s, respectively, while duration
time of tonic-clonic seizures reduced to 16.25± 2.39 s (P< 0.001
vs. saline group). In diazepam (1 mg/Kg) treated group, onset
times of myoclonic jerks and tonic-clonic seizures increased to
90.5 ± 2.53 and 130 ± 1.87 s, respectively, while duration time
of tonic-clonic seizures reduced to 12.5 ± 2.33 s (P < 0.001
vs. saline group). The saline treated group animals showed
100% mortality and immediately died. Vo.Cr at 100 mg/Kg and
300–500 mg/Kg doses reduced PTZ-induced seizures mortality
rate to 75 and 0% (P < 0.05, P < 0.001 vs. saline group)
respectively, while diazepam at test dose of 1 mg/Kg, reduced
mortality to 0% (P < 0.001 vs. saline group) as shown in
Table 1.
Effect on Time Spent in Open and Closed
Arms
Vo.Cr at 50–300 mg/Kg increased time spent by animals in open
arms, while decreased time spent in closed arms (Figure 2).
In control saline group, time spent in open and closed arms
were 23 ± 3.11 and 221 ± 9.57 s, respectively. In Vo.Cr
(50 mg/Kg) treated group, time spent in open arms increased
to 51.75 ± 4.72 s while time spent in closed arms reduced to
176 ± 7.52 s (P < 0.01 vs. saline group). In Vo.Cr (100 mg/Kg)
treated group, time spent in open arms increased to 113 ± 5.31 s
while time spent in closed arms reduced to 129.75 ± 5.59 s
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TABLE 1 | Effect of Verbena officinalis crude extract (Vo.Cr) and diazepam
on pentylenetetrazole (PTZ)-induced seizures mortality in mice.
Groups % Mortality
Saline (10 mL/Kg) + PTZ (90 mg/Kg) 100.00
Vo.Cr (100 mg/Kg) + PTZ (90 mg/Kg) 75.00∗
Vo.Cr (300 mg/Kg) + PTZ (90 mg/Kg) 0.00∗∗∗
Vo.Cr (500 mg/Kg) + PTZ (90 mg/Kg) 0.00∗∗∗
Diazepam (1 mg/Kg) + PTZ (90 mg/Kg) 0.00∗∗∗
Mortality = number of mice died after convulsion/total number of mice used
where % mortality = (number of mice died after convulsion/total number of mice
used) × 100. Data expressed as mean ± SEM, n = 4. ∗P < 0.05, ∗∗∗P < 0.001 vs.
saline group, one-way ANOVA with post-hoc Tukey test.
FIGURE 2 | Bar-graph showing effects of Verbena officinalis crude
extract (Vo.Cr) and diazepam on time spent by mice in open and
closed arms in elevated plus maze model. Data expressed as
mean ± SEM, n = 4. ∗∗P < 0.01, ∗∗∗P < 0.001 vs. saline group, one-way
ANOVA with post hoc Tukey test.
(P < 0.001 vs. saline group). In Vo.Cr (300 mg/Kg) treated
group, time spent in open arms was 58 ± 5.58 s while time
spent in closed arms was 169 ± 7.04 s (P < 0.01 vs. saline
group). In diazepam (2 mg/Kg) treated group, time spent in
open arms was increased to 94.5 ± 5.06 s while time spent in
closed arms reduced to 124.25 ± 9.41 s (P < 0.001 vs. saline
group).
Effect on Number of Entries in Open and
Closed Arms
Vo.Cr at 50–300 mg/Kg increased number of animals’ entries
into open arms, while decreased number of entries into closed
arms (Figure 3). In control saline group, numbers of entries
into open and closed arms were 5.75 ± 1.32 and 17.25 ± 1.75,
respectively. In Vo.Cr (50 mg/Kg) treated group, number of
entries into open arms increased to 12.5 ± 1.32, while number
of entries in closed arms reduced to 10.75 ± 0.63 (P < 0.05 vs.
saline group). In Vo.Cr (100 mg/Kg) treated group, number of
entries into open arms increased to 13.75 ± 1.11, while number
of entries in closed arms reduced to 8.0 ± 1.29 (P < 0.01 vs.
saline group). In Vo.Cr (300 mg/Kg) treated group, number
FIGURE 3 | Bar-graph showing effects of Verbena officinalis crude
extract (Vo.Cr) and diazepam on numbers of mice entries in open and
closed arms in elevated plus maze model. Data expressed as
mean ± SEM, n = 4. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. saline group,
one-way ANOVA with post hoc Tukey test.
of entries into open arms were 12.25 ± 1.38 (P < 0.05 vs.
saline group), while number of entries in closed arms reduced to
6.25 ± 1.32 (P < 0.001 vs. saline group). In diazepam (2 mg/Kg)
treated group, number of entries into open arms increased to
14.25± 1.25 (P < 0.01 vs. saline group), while number of entries
in closed arms reduced to 6.5 ± 1.94 (P < 0.001 vs. saline
group).
Effect on Time Spent in Light and Dark
Compartments
Vo.Cr at 50–300 mg/Kg increased time spent by animals in light
compartment, while decreased time spent in dark compartment
(Figure 4). In control saline group, times spent in light and
dark compartments were 88.5 ± 5.25 and 194.75 ± 7.25 s,
respectively. In Vo.Cr (50 mg/Kg) treated group, time spent in
light compartment increased to 138.75 ± 12.13 s, while time
spent in dark compartment reduced to 145 ± 9.25 s (P < 0.01
vs. saline group). In Vo.Cr (100 mg/Kg) treated group, time
spent in light compartment increased to 158 ± 9.46 s, while time
spent in dark compartment reduced to 134 ± 8.27 s (P < 0.001
vs. saline group). In Vo.Cr (300 mg/Kg) treated group, time
spent in light compartment was 142 ± 7.22 s, while time spent
in dark compartment was 151 ± 4.53 s (P < 0.01 vs. saline
group). In diazepam (2 mg/Kg) treated group, time spent in
light compartment was 140.5 ± 4.74 s, while time spent in dark
compartment was 144.5± 5.12 s (P < 0.01 vs. saline group).
Effect on Numbers of Ambulations,
Rearings, and Central Squares Crossings
Vo.Cr at highest tested dose of 300 mg/Kg, significantly decreased
numbers of animals’ ambulations and rearings frequencies,
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FIGURE 4 | Bar-graph showing effects of Verbena officinalis crude
extract (Vo.Cr) and diazepam on time spent by mice in light and dark
compartments in light–dark box model. Data expressed as mean ± SEM,
n = 4. ∗∗P < 0.01, ∗∗∗P < 0.001 vs. saline group, one-way ANOVA with post
hoc Tukey test.
while increased the number of central squares crossings at
all tested doses (50–300 mg/Kg) compared to control saline
group, as presented in Figure 5. In saline group, numbers
of ambulations, rearings, and central squares crossings were
121.75 ± 9.71, 52.25 ± 4.52, and 6.25 ± 0.85, respectively.
In Vo.Cr (50 mg/Kg) treated group, numbers of ambulations
and rearings were 109.5 ± 8.06 and 42.5 ± 2.22 (P > 0.05
vs. saline group) respectively, while number of central squares
crossings increased to 11.25 ± 0.85 (P < 0.01 vs. saline group).
In Vo.Cr (100 mg/Kg) treated group, numbers of ambulations
and rearings were 106.5 ± 4.03 and 39.5 ± 2.9 (P > 0.05
vs. saline group) respectively, while number of central squares
crossings increased to 15 ± 0.41 (P < 0.001 vs. saline group).
In Vo.Cr (300 mg/Kg) treated group, numbers of ambulations
and rearings reduced to 74.25 ± 3.30 and 24.25 ± 1.97
respectively (P < 0.001 vs. saline group), while number of
central squares crossings were 10.75 ± 0.85 (P < 0.01 vs.
saline group). In diazepam (2 mg/Kg) treated group, numbers of
ambulations and rearings decreased to 70± 4.66 and 15.25± 2.96
respectively (P < 0.001 vs. saline group), while number of central
squares crossings increased to 11 ± 0.91 (P < 0.01 vs. saline
group).
Effect on Thiopental-Induced Sleeping
Time
Vo.Cr dose-dependently (50–300 mg/Kg) decreased
animals’ onset time of sleep, while increased sleep duration
(Figures 6A,B). In control saline group, onset and duration of
sleep times were 3.53 ± 0.27 and 8.25 ± 1.16 min, respectively.
In Vo.Cr (50 mg/Kg) treated group, onset time of sleep
decreased to 2.61 ± 0.21 min (P < 0.05 vs. saline group), while
duration of sleep time was increased to 14.50 ± 1.57 min. In
FIGURE 5 | Bar-graph showing effects of Verbena officinalis crude
extract (Vo.Cr) and diazepam on numbers of mice ambulations,
rearings, and central squares crossings in open field model. Data
expressed as mean ± SEM, n = 4. ∗∗P < 0.01, ∗∗∗P < 0.001 vs. saline
group, one-way ANOVA with post hoc Tukey test.
Vo.Cr (100 mg/Kg) treated group, onset time of sleep was
decreased to 2.39 ± 0.04 min, while duration of sleep time
was increased to 66.45 ± 6.13 min (P < 0.01 vs. saline group).
In Vo.Cr (300 mg/Kg) treated group, onset time of sleep
was further decreased to 1.6 ± 0.14 min, while duration of
sleep time was increased to 523.65 ± 13.03 min (P < 0.001
vs. saline group). In diazepam (3 mg/Kg) treated group,
onset time of sleep was 1.32 ± 0.05 min, while duration
of sleep time was 571.8 ± 12.17 min (P < 0.001 vs. saline
group).
Acute Toxicity
Vo.Cr at higher doses of 3 and 5 g/Kg, i.p. did not caused any
mortality, but only decreased locomotor activity of mice showing
sedative effect.
DISCUSSION
We employed different pharmacological techniques, to
investigate anticonvulsant, anxiolytic and sedative effects of
Verbena officinalis. PTZ-induced seizure is commonly used
animal model for screening of anti-seizure drugs (Loscher and
Schmidt, 1988; Okoye et al., 2013). Vo.Cr caused marked delay in
onset time of both myoclonic jerks and tonic-clonic seizures, as
well as decreased duration of tonic-clonic seizures and animals’
mortality, demonstrating its anti-epileptic effect. PTZ evokes
convulsions via inhibition of GABAergeic neurotransmissions by
interfering with GABAA receptors (Ramanjaneyulu and Ticku,
1984). Dr. Thomas B. Turnbaugh in his professional experience
observed verbenin, an iridoid glycoside, obtained from Verbena
hastate more beneficial than bromide for epilepsy treatment. He
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FIGURE 6 | Bar-graph showing effects of Verbena officinalis crude
extract (Vo.Cr) and diazepam on (A) onset time of sleep and (B) duration of
sleep in thiopental-induced sleeping test in mice. Data expressed as
mean ± SEM, n = 4. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 vs. saline group,
one-way ANOVA with post hoc Tukey test.
favored verbenin that it has no injurious effects and its use makes
the patient more cheerful and alert instead of bromide which
makes the patient stupid and dull (French, 1908). Verbenin is also
the main constituent of Verbena officinalis (Duke, 1992) which
might be responsible for its anticonvulsant activity. Verbena
officinalis is known to contain a constituent, 4-(1-methylethyl)-
benzylic alcohol safranal (Gharachorloo and Amouheidari,
2016) and safranal from Crocus sativus plant has been reported
for its anti-seizure action by virtue of GABAA receptors
stimulation (Hosseinzadeh and Talebzadeh, 2005; Hosseinzadeh
and Sadeghnia, 2007), suggesting that anticonvulsant effect of
Verbena officinalis might possibly occurred through activation
of GABAA receptors by safranal. EPM and LDB models are
favorable for testing of GABAA-receptors linked anxiolytic drugs
(Emamghoreishi et al., 2005; Mesfin et al., 2014). Agents, which
increase animals’ time spent and number of entries into open
arms and/or reducing these phenomenon in closed arms in EPM,
also increase animals’ time spent in light compartment and/or
reducing these phenomenon in dark compartment in LDB,
are considered to possess anxiolytic effects (Hellion-Ibarrola
et al., 2006). Vo.Cr significantly increased time spent and
number of entries into open arms, while deceased time spent
and number of entries into closed arms, as well as increased
time spent in light compartment, while deceased time spent in
dark compartment, like that caused by diazepam, a standard
benzodiazepine anxiolytic medicine (Griebel et al., 1998). At the
100 mg/Kg dose, Vo.Cr showed maximum anxiolytic effect, but
at next highest tested dose (300 mg/Kg), its effect was reduced,
because of decreased exploratory activities, possibly be due to
co-existent sedative component of the plant. Verbena officinalis
has been reported for presence of flavonoids (apigenin, luteolin,
quercetion, kaempferol) and tannins (Mengiste et al., 2014;
Edwards et al., 2015), which are well-known for their anxiolytic
and central nervous system depressant (sedative) activities
(Adeyemi et al., 2006; Coleta et al., 2008; Aguirre-Hernandez
et al., 2010). Several flavonoids bind to the benzodiazepine
site on GABAA-receptors to provoke anti-seizure, anti-anxiety
and sedative effects (Jager and Saaby, 2011), evidencing that
observed actions of Verbena officinalis mediated possibly
through activation of GABAA-receptors pathway. However,
involvement of other contributing mechanism(s) cannot be
ignored. In open field test principle, increased number of
ambulations, rearings and central squares crossings reveal
anxiolytic activity, while reduction in locomotion showed
sedative effect. Vo.Cr at lower doses of 50–100 mg/Kg did not
produced statistically any prominent difference in ambulation
and rearing frequencies, compared to saline group (P > 0.05),
but both ambulation and rearing frequencies were significantly
reduced at highest dose of 300 mg/Kg (P < 0.001 vs. saline
group). The decreased locomotor activity at higher dose of Vo.Cr
might be due to sedative effect of the plant. Vo.Cr, at all tested
doses (50–300 mg/Kg) significantly increased numbers of central
squares crossings, showing its anxiolytic activity. Diazepam,
a reference drug also reduced both ambulation and rearing
frequencies, because of its sedative property, while increased the
number of central squares crossings, due to owning anxiolytic
profile (Ramos, 2008). Benzodiazepines are well-established for
anxiolytic effect at lower doses and sedative, muscle relaxant
and anti seizure effects at higher doses (Melo et al., 2006).
Substances that have sedative effect either decrease onset time
of sleep and/or prolong duration of sleep (Raquibul-Hasan
et al., 2009). In thiopental-induced sleeping assay, Vo.Cr in
dose-dependent manner decreased onset time of sleep, while
increased duration of sleep, indicating its sedative activity,
further confirming that the decreased locomotor activity of mice
in EPM, light–dark and open field tests was due to sedative effect
of the plant test extract. Flavonoids like scutellarein and phenolic
acid derivatives like verbascoside have been reported for their
sedative effects but they have low affinity for benzodiazepine
site on GABAA receptor. The authors suggest that they could
induce CNS activities through different mechanism like
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inhibition of the N-methyl-D-aspartate or serotonin receptors
and the type of sugar linkage with the aglycone should be
an important factor for their sedative activities (De Santana
Julião et al., 2010). Scutellarein and verbascoside are the main
constituents of Verbena officinalis (Rehecho et al., 2011), so
sedative effect of Verbena officinalis may be due to these
constituents possibly through GABA pathways by acting on sites
other than benzodiazepine ones or through pathways other than
GABAergic system.
CONCLUSION
The present study reveals that Verbena officinalis exhibits
anticonvulsant, anxiolytic and sedative effects, which validates
its folk use in neurological disorders and a step forward toward
exploration of evidence-based alternative medicines. Further in-
depth advance molecular studies are warranted to elucidate
pharmacodynamics basis of the pharmacological actions.
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